Introducing a probabilistic definition of the target in a robust treatment planning framework
- 8 July 2021
- journal article
- research article
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 66 (15), 155008
- https://doi.org/10.1088/1361-6560/ac1265
Abstract
The "clinical target distribution" (CTD) has recently been introduced as a promising alternative to the binary clinical target volume (CTV). However, a comprehensive study that considers the CTD, together with geometric treatment uncertainties, was lacking. Because the CTD is inherently a probabilistic concept, this study proposes a fully probabilistic approach that integrates the CTD directly in a robust treatment planning framework. First, the CTD is derived from a reported microscopic tumor infiltration model such that it explicitly features the probability of tumor cell presence in its target definition. Second, two probabilistic robust optimization methods are proposed that evaluate CTD coverage under uncertainty. The first method minimizes the expected-value (EV) over the uncertainty scenarios and the second method minimizes the sum of the expected value and standard deviation (EV-SD), thereby penalizing the spread of the objectives from the mean. Both EV and EV-SD methods introduce the CTD in the objective function by using weighting factors that represent the probability of tumor presence. The probabilistic methods are compared to a conventional worst-case approach that uses the CTV in a worst-case optimization algorithm. To evaluate the treatment plans, a scenario-based evaluation strategy is implemented that combines the effects of microscopic tumor infiltrations with the other geometric uncertainties. The methods are tested for five lung tumor patients, treated with intensity-modulated proton therapy. The results indicate that for the studied patient cases, the probabilistic methods favor the reduction of the esophagus dose but compensate by increasing the high-dose region in a low conflicting organ such as the lung. These results show that a fully probabilistic approach has the potential to obtain clinical benefits when tumor infiltration uncertainties are taken into account directly in the treatment planning process.Funding Information
- Fonds De La Recherche Scientifique - FNRS (7453918F)
This publication has 28 references indexed in Scilit:
- Probabilistic objective functions for margin-less IMRT planningPhysics in Medicine & Biology, 2013
- A characterization of robust radiation therapy treatment planning methods—from expected value to worst case optimizationMedical Physics, 2012
- Range uncertainties in proton therapy and the role of Monte Carlo simulationsPhysics in Medicine & Biology, 2012
- Robust optimization of intensity modulated proton therapyMedical Physics, 2012
- Noninvasive Evaluation of Microscopic Tumor Extensions Using Standardized Uptake Value and Metabolic Tumor Volume in Non-Small-Cell Lung CancerInternational Journal of Radiation Oncology*Biology*Physics, 2011
- Minimax optimization for handling range and setup uncertainties in proton therapyMedical Physics, 2011
- The International Commission on Radiation Units and MeasurementsJournal of the ICRU, 2010
- Reducing the sensitivity of IMPT treatment plans to setup errors and range uncertainties via probabilistic treatment planningMedical Physics, 2008
- Worst case optimization: a method to account for uncertainties in the optimization of intensity modulated proton therapyPhysics in Medicine & Biology, 2008
- On the implementation of an interior-point filter line-search algorithm for large-scale nonlinear programmingMathematical Programming, 2005